2020 American Transplant Congress
The Incidence, Clinical Characteristics and Prophylactic Strategy of Invasive Fungal Infections in Lung Transplantation
*Purpose: Invasive Fungal infections in lung transplant recipients(LTR) were common and harmful, remaining a major cause of morbidity and mortality after lung transplantation. The incidence,…2020 American Transplant Congress
Impact of Frailty on Early and Late Hospital Readmission after Kidney Transplantation
*Purpose: Currently there are no tools to predict outcomes after kidney transplantation (KTx). This study assesses whether frailty influences post-KTx complications. Understanding frailty and its…2020 American Transplant Congress
Kidney Transplantation from HBsAg+ Living Donors to HBsAg- Recipients: A Propensity Score-Matched Study at a High-Volume Center in China
Urology, West China Hospital, Chengdu, China
*Purpose: Data on kidney transplantation (KTx) from hepatitis B surface antigen (HBsAg)+ donors to HBsAg- recipients [D(HBsAg+)/R(HBsAg-)] are limited. We aimed to report the outcomes…2020 American Transplant Congress
Epidemiology of Invasive Fungal Infections in Heart Transplant Recipients
*Purpose: The incidence and epidemiology of invasive fungal infections (IFI) after heart transplantation (HTx) are influenced by changes in environmental exposures, immunosuppression, and prophylaxis practices.…2020 American Transplant Congress
Differences in Alemtuzumab Dosing Does Not Affect Early Kidney Transplant Outcomes
Wake Forest Baptist Health, Winston-Salem, NC
*Purpose: Alemtuzumab (Alem) is a widely used medication for induction therapy in kidney transplantation. However, there is limited evidence comparing outcomes with low versus high…2020 American Transplant Congress
Impact of Organ Donor Infections on Kidney Transplant Recipient Outcomes
*Purpose: Donor-derived infections can lead to significant morbidity and mortality in organ transplant recipients. There is variability by center on treatment of positive donor cultures…2020 American Transplant Congress
Phage Therapy for Mycobacterium Abscessus (Mab) Infection after Lung Transplant (LT)
*Purpose: LT recipients with Mab infections have poor outcomes. We describe a patient with refractory Mab infection treated with mycobacteriophage therapy.*Methods: A 56-year-old woman with…2020 American Transplant Congress
Clinical Correlations Associated with Development of De Novo Donor-Specific Antibody in the First Year Following Kidney Transplant at a Single Center
1Ohio State University, Columbus, OH, 2Robert Wood Johnson Barnabas Health, New Brunswick, NJ
*Purpose: The development of de novo donor-specific antibody (dnDSA) portends inferior long-term graft survival. This study investigates the short-term clinical correlations associated with dnDSA that…2020 American Transplant Congress
Management of Adenovirus Enteritis after Intestinal Transplantation
*Purpose: Solid organ transplant recipients are at risk for infection, in part due to immunosuppression. Adenovirus enteritis (AE) is one possible clinical presentation of infection…2020 American Transplant Congress
Change in the Willingness of Transplant Candidates to Accept Hepatitis C Virus Positive Deceased Donor Organs in the Era of Direct-Acting Antivirals
Transplant Center, Massachusetts General Hospital，Harvard Medical School, Boston, MA
*Purpose: Direct-acting antiviral (DAA) medications’ advent in 2014 very effectively changed the hepatitis C virus (HCV) treatment landscape and allowed post-transplant HCV therapy. We aimed…
- « Previous Page
- 1
- …
- 25
- 26
- 27
- 28
- 29
- …
- 84
- Next Page »